Navigation Links
Intravenous gene therapy protects normal tissue of mice during whole-body radiation
Date:10/28/2007

LOS ANGELES, Oct. 28 Gene therapy administered intravenously could be an effective agent to protect vital organs and tissues from the effects of ionizing radiation in the event of large-scale exposure from a radiological or nuclear bomb, according to an animal study presented today by University of Pittsburgh researchers at the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.

Ionizing radiation can be extremely damaging to cells, tissues, organs and organ systems, said Joel S. Greenberger, M.D., professor and chairman, department of radiation oncology, University of Pittsburgh School of Medicine. In previous studies, we demonstrated that gene therapy can be both swallowed in liquid form and inhaled through a nebulizer prior to radiation exposure to protect healthy tissues from damage. In this study, we found that the same therapy administered intravenously also offers protection during exposure to whole-body irradiation. Dr. Greenberger added that intravenous administration could potentially offer wide-reaching protection to the public in the event of a terrorist attack since experts believe a significant number of the population would die within 30 days of receiving a large dose of radiation to the entire body.

In the study, mice were used to test the protective effects of manganese superoxide dismutase plasmid liposome (MnSOD-PL) gene therapy on the bone marrow during whole-body irradiation. The researchers found that in a control group of mice that received an initial 9.5 Gy dose of radiation, 58 percent survived at 30 days compared to 90 percent after the same length of time for an experimental group of mice that were injected with MnSOD-PL prior to irradiation. Between 30 and 330 days, there were no differences in survival rates between experiment and control group mice, indicating that systemic MnSOD-PL treatment was not harmful to survival.

Intravenous administrat
'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
2. Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Gene therapy converts dead bone graft to new, living tissue
7. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. Gene Therapy For Parkinsons Disease Moves Forward In Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...alian researchers and a pathology company have joi...system which may reveal a way to predict premature...Melbourne, the University of Newcastle and Symbion...earch, engineering and pathology to develop a comp...ure birth., About 17,000 pre-term births occur in...
(Date:9/4/2008)...s press release is available in German . , Cyst...arcinoma: Many diseases of the excretory organs ar...ary absence of characteristic proteins in the ren... leadership of scientists from DKFZ and Heidelberg...model to better investigate these conditions. , ...
(Date:9/4/2008)...IDENCE New research from Rhode Island Hospital fo...M) can contribute to mild neurodegeneration with f...first study to show that obesity can cause neurode...Alzheimer,s Disease Volume 15:1 (September 2008) ...r Suzanne de la Monte, MD, MPH, of Rhode Island Ho...
(Date:9/3/2008)...ladelphia, PA September 4, 2008) The tumor suppre...ent prognostic biomarker in cases of soft tissue s...oration of researchers, including scientists at th...ar Medicine at the College of Science and Technolo...epartment of Human Pathology and Oncology, Univers...
Breaking Biology News(10 mins):World-first to predict premature births 2Gaining a better understanding of kidney diseases 2International team reveals first prognosticator of survival in aggressive cancer 2Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 1Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 2Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 3Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 4Lupus Foundation of America Webchat to Discuss Kidney Disease in Lupus 13640 1Lupus Foundation of America Webchat to Discuss Kidney Disease in Lupus 13640 2Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 1Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 2Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 3Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 4Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 5Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 1Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 2Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 3
... believing, especially in medicine. From magnetic ...) scan, images of the body’s tissues and organs ha...nose disease and make recommendations for effectiv...nology developed at Kent State University will pro...to evaluate medical images that are commonly used....
...s ability to replace the tissue it sloughs off is ... Harvard Medical School published in the May 4 iss...r" of this regeneration process not only for skin,... prostate, and urogenital tract. This master regul...p63 gene, a close relative to the well-known tumor...
...y of Manchester researchers are ridding diabetic p...oot ulcers with maggots. , Professor Andrew Boulto...at 13 diabetic patients whose foot ulcers were con...ed within a mean period of three weeks, much quick...treatment. , Professor Boulton, who published t...
... clinical trial to test a revolutionary treatment ...searchers at UCL (University College London). The ...first of its kind and could have a significant imp...trial involves adults and children who have a cond...hich is a type of inherited retinal degeneration. ...
Other Biology News:Novel system developed to turn data into real-time, interactive 3-D images 2Master regulatory gene of epithelial stem cells identified 2Maggots rid patients of MRSA 2First clinical trial of gene therapy for childhood blindness 2
(Date:9/3/2008).../- Wyeth (NYSE: WYE ),toda... 54, to Vice,President, Corporate Communications. ...t, Corporate Affairs, Mr. McIntyre will be respons...for the corporation and its three,major divisions ...l health,-- around the world., Prior to joining W...
(Date:9/3/2008)...eeting to be held September 24 to 26 in Kansas Cit...) September 3, 2008 -— The U.S. Pharmacopeia...Meeting (ASM) will be held in Kansas City, Mo., Se... interact with the USP experts responsible for est... prescription and over-the-counter medicines, food...
(Date:9/3/2008).... 3 /- ESA Biosciences, a Magellan,Bi...on systems that improve,results for pharmaceutical...al-chemistry customers worldwide, announced that i...rican Technology Innovation Award in the,field of ...will present the,award to ESA,s Vice President of ...
(Date:9/3/2008)...swire/ -- US Oncology Specialty, LP, the,state-of-...ncology, has,received the Occupational Excellence ... for its outstanding safety achievements., The aw...t of the best",in safety and safety performance. T... from work resulting from workplace injuries or il...
Breaking Biology Technology:Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications 2USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 2USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 3ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 2ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 3US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award 2
...Dillione is president of the health services divis...ld,s largest medical technology companies. She has...of University of Wisconsin Hospitals and Clinics ... in healthcare by Modern Healthcare magazine. ,...view with Dillione. , , WTN: With respec...
... first indication of how they view the Viasys Hea...l Health say they are excited about the growth po... part of a merger agreement between Cardinal Healt...uire Viasys, parent of the NeuroCare Group, for $1...boards of directors. , ,In a conference call with...
... survived two rounds of judging, 26 entries from 1...f the fourth annual Wisconsin Governor,s Business...nding from a pool of nearly 300 entries statewide,... strengths, according Mark Bugher, chairman of the...ng plans include ideas for products or services in...
...rms is writing a series of articles on raising cap...s installment focuses on the Private Placement Mem...a. , , We are frequently asked whether it is nec... referred to as a PPM or an offering memorandum) w...vate placement. Once we tell them yes, it,s genera...
Other Biology Technology:Siemens health services president calls IT benefits unassailable 2Siemens health services president calls IT benefits unassailable 3Siemens health services president calls IT benefits unassailable 4Siemens health services president calls IT benefits unassailable 5Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Business plan finalists capture technology 2When raising capital, why use a Private Placement Memorandum? 2When raising capital, why use a Private Placement Memorandum? 3When raising capital, why use a Private Placement Memorandum? 4When raising capital, why use a Private Placement Memorandum? 5
Plasmid expressing PLAP reporter gene.
Blasticidin resistance gene (bsr), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin.
... have triple baffles located at the center of the ... culture medium. These flasks have a large marking...e for these bottles including:, Polypropylene col... Vented membrane cap with 0.22m PTFE hydrophobic m...
Columbus from Tecan
Biology Products: